34
Views
0
CrossRef citations to date
0
Altmetric
Review

Anti-αβ-T-Cell Receptor Antibodies in the Setting of Laryngeal Transplantation

&
Pages 835-845 | Published online: 22 Nov 2010

Bibliography

  • Moloney FJ , ComberH, O‘LorcainP, O‘KellyP, ConlonPJ, MurphyGM: A population-based study of skin cancer incidence and prevalence in renal transplant recipients.Br. J. Dermatol.154(3) , 498–504 (2006).
  • Tsuchida M , HiraharaH, MatsumotoY, AboT, EguchiS: Induction of specific unresponsiveness to cardiac allografts by short-term administration of anti-T cell receptor α β antibody.Transplantation57(2) , 256–262 (1994).
  • Dufter C , PostS, ThiesJ et al.: Short-term T cell receptor directed immunotherapy induces organ specific peripheral tolerance in a strongly incompatible rat model.Transplant. Immunol.2(4) , 278–284 (1994).
  • Heidecke CD , HancockWW, JakobsF et al.: α/β-TCR-directed therapy in rat cardiac allograft recipients: treatment prior to alloantigen exposure prevents sensitization and abrogates accelerated rejection.Transplantation59(1) , 78–84 (1995).
  • van den Bogaerde J , WhiteD, RoserB, KampingaJ, AspinallR: In vitro and in vivo effects of monoclonal antibodies against T cell subsets on allogeneic and xenogeneic responses in the rat.Transplantation50(6) , 915–920 (1990).
  • Yoshino S , SchlipkoterE, KinneR, HünigT, EmmrichF: Suppression and prevention of adjuvant arthritis in rats by a monoclonal antibody to the α/β T cell receptor.Eur. J. Immunol.20(12) , 2805–2808 (1990).
  • Jung S , KramerS, SchluesenerHJ, HünigT, ToykaK, HartungHP: Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-α/β.J. Immunol.148(12) , 3768–3775 (1992).
  • Yoshino S , ClelandLG, MayrhoferG, BrownRR, SchwabJH: Prevention of chronic erosive streptococcal cell wall-induced arthritis in rats by treatment with a monoclonal antibody against the T cell antigen receptor α β.J. Immunol.146(12) , 4187–4189 (1991).
  • Bluestone JA , KhattriR, SciammasR, SperlingAI: TCR γδ cells: a specialized T-cell subset in the immune system.Annu. Rev. Cell Dev. Biol.11 , 307–353 (1995).
  • Hall BM : Cells mediating allograft rejection.Transplantation51(6) , 1141–1151 (1991).
  • Lin J , WeissA: T cell receptor signaling.J. Cell Sci.114(Pt 2) , 243–244 (2001).
  • Okkenhaug K , BilancioA, EmeryJL, VanhaesebroeckB: Phosphoinositide 3-kinase in T cell activation and survival.Biochem. Soc. Trans.32(Pt 2) , 332–335 (2004).
  • Davis MM : A new trigger for T cells.Cell110(3) , 285–287 (2002).
  • Coombs D , KalergisAM, NathensonSG, WofsyC, GoldsteinB: Activated TCRs remain marked for internalization after dissociation from pMHC.Nat. Immunol.10 , 926–931 (2002).
  • Okkenhaug K , VanhaesebroeckB: PI3K in lymphocyte development, differentiation and activation.Nat. Rev. Immunol.3(4) , 317–330 (2003).
  • Holtmeier W , KabelitzD: γδ T cells link innate and adaptive immune responses.Chem. Immunol. Allergy86 , 151–183 (2005).
  • Starzl TE , DemetrisAJ, MuraseN, IldstadS, RicordiC, TruccoM: Cell migration, chimerism, and graft acceptance.Lancet339(8809) , 1579–1582 (1992).
  • Starzl TE , ZinkernagelRM: Antigen localization and migration in immunity and tolerance.N. Engl. J. Med.339(26) , 1905–1913 (1998).
  • Murase N , StarzlTE, TanabeM et al.: Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats.Transplantation60(2) , 158–171 (1995).
  • Heidecke CD , ZantlN, MaierS et al.: Importance of T cells to accelerated rejection and acceptance of renal allografts in sensitized rat recipients.Transplantation66(10) , 1354–1361 (1998).
  • Hamano K , ItoH, ShirasawaB et al.: Anti-α β-T cell receptor monoclonal antibody induces tolerance without dominant infiltration by Th2 cells into grafts.Transplant Proc.30(7) , 3892 (1998).
  • Heidecke CD , HancockWW, WesterholtS: α/β-T cell receptor-directed therapy in rat allograft recipients. Long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokines.Transplantation61(6) , 948–956 (1996).
  • Heidecke CD , ZantlN, MaierS et al.: Induction of long-term rat renal allograft survival by pretransplant T cell receptor-α/β-targeted therapy.Transplantation61(2) , 336–339 (1996).
  • Henrickson M , ReidJ, BelletJS, SawchukSS, HirschR: Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR α β (H57-597) and CD3 (145-2C11).Transplantation60(8) , 828–835 (1995).
  • Darby CR , MorrisPJ, WoodKJ: Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ T cells.Transplantation.54(3) , 483–490 (1992).
  • Gutstein NL , WofsyD: Administration of F(ab‘)2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.J. Immunol.137(11) , 3414–3419 (1986).
  • Tanaka K , HancockWW, OsawaH et al.: Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.J. Immunol.143(9) , 2873–2879 (1989).
  • Siemionow M , OrtakT, IzyckiD et al.: Induction of tolerance in composite-tissue allografts.Transplantation74(9) , 1211–1217 (2002).
  • Black KS , HewittCW, FraserLA et al.: Composite tissue (limb) allografts in rats. II. Indefinite survival using low-dose cyclosporine.Transplantation39(4) , 365–368 (1985).
  • Brazelton TR , MorrisRE: Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.Curr. Opin. Immunol.8(5) , 710–720 (1996).
  • Knight RJ , KurrleR, McClainJ et al.: Clinical evaluation of induction immunosuppression with a murine IgG2b monoclonal antibody (BMA 031) directed toward the human α/β-T cell receptor.Transplantation57(11) , 1581–1588 (1994).
  • Ozer K , IzyckiD, ZielinskiM, SiemionowM: Development of donor-specific chimerism and tolerance in composite tissue allografts under αβ-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols.Microsurgery24(3) , 248–254 (2004).
  • Siemionow MZ , IzyckiDM, ZielinskiM: Donor-specific tolerance in fully major histocompatibility major histocompatibility complex mismatched limb allograft transplants under an Anti-αβ T-cell receptor monoclonal antibody and cyclosporine A protocol.Transplantation76(12) , 1662–1668 (2003).
  • Siemionow M , KlimczakA, UnalS, AgaogluG, CarnevaleK: Hematopoietic stem cell engraftment and seeding permits multi-lymphoid chimerism in vascularized bone marrow transplants.Am. J. Transpl.8(6) , 1163–1176 (2008).
  • Siemionow M , NasirS: Impact of donor bone marrow on survival of composite tissue allografts.Ann. Plast. Surg.60(4) , 455–462 (2008).
  • Prabhune KA , GorantlaVS, Perez-AbadiaG et al.: Composite tissue allotransplantation in chimeric hosts Part II. A clinically relevant protocol to induce tolerance in a rat model.Transplantation76(11) , 1548–1555 (2003).
  • Knott PD , DanO, StromeM: Induction with T-cell receptor antibody leads to long-term laryngeal allograft function.Am. J. Otol.29(6) , 398–402 (2008).
  • Akst LM , SiemionowM, DanO, IzyckiD, StromeM: Induction of tolerance in a rat model of laryngeal transplantation.Transplantation76(12) , 1763–1770 (2003).
  • Khariwala SS , DanO, LorenzRR, KlimczakA, SiemionowM, StromeM: Donor bone marrow in laryngeal transplantation: results of a rat study.Amer. J. Otol.29(4) , 242–249 (2008).
  • Khariwala SS , KnottPD, DanO, KlimczakA, SiemionowM, StromeM: Pulsed immunosuppression with everolimus and Anti-αβ T-cell receptor: laryngeal allograft preservation at six months.Ann. Otol. Rhinol. Laryngol.115(1) , 74–80 (2006).
  • Lott DG , KhariwalaS, DanO, StromeM: Ten-month laryngeal allograft survival using pulsed everolimus and Anti-αβ TCR antibody immunosuppression.Ann. Otol. Rhinol. Laryngol. (2010) (In Press).
  • Binder J , LehmannM, GraserE et al.: The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.Transplantation61(5) , 804–811 (1996).
  • Hancock WW , SayeghMH, SablinskiT, KutJP, Kupiec-WeglinskiJW, MilfordEL: Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.Transplantation53(6) , 1276–1280 (1992).
  • Sablinski T , SayeghMH, KutJP, MilfordEL, TilneyNL, Kupiec-WeglinskiJW: Evidence that therapeutic strategies targeted at CD4+ cells modulate accelerated rejection of cardiac allografts in sensitized rats by different mechanisms.Transplantation54(2) , 292–296 (1992).
  • Hunig T , WallnyHJ, HartleyJK, LawetzkyA, TiefenthalerG: A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes.J. Exp. Med.169(1) , 73–86 (1989).
  • Cobbold SP , JayasuriyaA, NashA, ProsperoTD, WaldmanH: Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.Nature312(5994) , 548–551 (1984).
  • Schwartz RH : A cell culture model for T lymphocyte clonal anergy.Science248(4961) , 1349–1356 (1990).
  • Rammensee HG , KroschewskiR, FrangoulisB: Clonal anergy induced in mature Vβ6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells.Nature339(6225) , 541–544 (1989).
  • Foster RD , LiuT: Orthotopic hindlimb transplantation in the mouse.J. Recon. Microsurg.19(1) , 49–52; discussion, 53–54 (2003).
  • Dallman MJ , LarsenCP, MorrisPJ: Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction.J. Exp. Med.174(2) , 493–496 (1991).
  • Mottram PL , HanWR, PurcellLJ, McKenzieIFC, HancockWW: Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long-surviving mouse heart allografts after brief CD4- monoclonal antibody therapy.Transplantation59(4) , 559–565 (1995).
  • Mosmann TR , MooreKW: The role of IL-10 in crossregulation of TH1 and Th2 responses.Immunol. Today12(3) , A49–A53 (1991).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.